JP2022515067A5 - - Google Patents
Info
- Publication number
- JP2022515067A5 JP2022515067A5 JP2021534753A JP2021534753A JP2022515067A5 JP 2022515067 A5 JP2022515067 A5 JP 2022515067A5 JP 2021534753 A JP2021534753 A JP 2021534753A JP 2021534753 A JP2021534753 A JP 2021534753A JP 2022515067 A5 JP2022515067 A5 JP 2022515067A5
- Authority
- JP
- Japan
- Prior art keywords
- methylcellulose
- anhydroglucose
- anhydroglucose unit
- hydroxyl groups
- methyl groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18213440 | 2018-12-18 | ||
| EP18213440.3 | 2018-12-18 | ||
| PCT/US2019/066704 WO2020131780A1 (en) | 2018-12-18 | 2019-12-17 | A sustained release composition comprising a methylcellulose |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022515067A JP2022515067A (ja) | 2022-02-17 |
| JP2022515067A5 true JP2022515067A5 (https=) | 2024-04-16 |
| JP7535519B2 JP7535519B2 (ja) | 2024-08-16 |
Family
ID=64744643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534753A Active JP7535519B2 (ja) | 2018-12-18 | 2019-12-17 | メチルセルロースを含む徐放性組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20220031623A1 (https=) |
| EP (1) | EP3897729B8 (https=) |
| JP (1) | JP7535519B2 (https=) |
| WO (1) | WO2020131780A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025525831A (ja) | 2022-08-02 | 2025-08-07 | ニュートリション アンド バイオサイエンシズ ユーエスエー 1,リミティド ライアビリティ カンパニー | アルギネートをベースとする放出調節組成物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2917104A1 (de) | 1979-04-27 | 1980-11-06 | Hoechst Ag | Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung |
| JPS6225101A (ja) | 1985-07-24 | 1987-02-03 | Shin Etsu Chem Co Ltd | 低重合度セルロ−スエ−テルの製造方法 |
| US4734285A (en) | 1985-10-28 | 1988-03-29 | The Dow Chemical Company | Sustained release compositions |
| US6261218B1 (en) | 1998-12-01 | 2001-07-17 | The Dow Chemical Company | Process and apparatus for making low molecular weight cellulose ethers |
| AU3932400A (en) | 1999-04-01 | 2000-10-23 | Dow Chemical Company, The | Enhanced gel strength methylcellulose |
| RU2325152C2 (ru) * | 2001-07-04 | 2008-05-27 | Сан Фармасьютикл Индастриз Лимитид | Удерживаемая в желудке система регулируемой доставки лекарственного средства |
| DE10141680B4 (de) | 2001-08-25 | 2004-02-26 | Clariant Gmbh | Verfahren zur Herstellung niederviskoser Celluloseether durch sauer-oxidativen Abbau von gemahlenen und getrockneten Celluloseethern |
| KR20140077975A (ko) | 2011-10-19 | 2014-06-24 | 다우 글로벌 테크놀로지스 엘엘씨 | 포만감을 유발하는 방법 및 조성물 |
| BR112014008689A2 (pt) | 2011-10-19 | 2017-04-25 | Dow Global Technologies Llc | medicamento fluível ou ingerível por colher, alimento, ingrediente alimentício ou suplemento alimentar, método para induzir saciedade ou para reduzir reversivelmente o volume vazio do estômago em um indivíduo e método para reduzir a ingestão calórica em um indivíduo |
| WO2014168914A1 (en) | 2013-04-12 | 2014-10-16 | Dow Global Technologies Llc | Water-soluble polysaccharides of improved palatability |
| KR20140133724A (ko) | 2013-05-10 | 2014-11-20 | 한양대학교 산학협력단 | 저분자 메틸셀룰로오스 기반의 비경구 약물 전달 시스템 |
| WO2015009796A1 (en) * | 2013-07-17 | 2015-01-22 | Dow Global Technologies Llc | Composition for application to a mucosa comprising a methylcellulose |
| US20160317388A1 (en) | 2014-05-01 | 2016-11-03 | Sun Pharmaceutical Industries Limited | Dual-chamber pack for extended release suspension compositions |
| MA41124A (fr) | 2014-12-05 | 2017-10-10 | Sun Pharmaceutical Ind Ltd | Compositions en suspension à libération prolongée à rétention gastrique |
| EP3216807B2 (en) | 2016-03-09 | 2022-05-18 | Shin-Etsu Chemical Co., Ltd. | Coating composition containing methyl cellulose, method for producing the same, and solid preparation |
-
2019
- 2019-12-17 US US17/312,411 patent/US20220031623A1/en not_active Abandoned
- 2019-12-17 EP EP19836895.3A patent/EP3897729B8/en active Active
- 2019-12-17 WO PCT/US2019/066704 patent/WO2020131780A1/en not_active Ceased
- 2019-12-17 JP JP2021534753A patent/JP7535519B2/ja active Active
-
2025
- 2025-03-17 US US19/081,897 patent/US20250248943A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102072371B1 (ko) | 7-[4-(4-벤조[b]티오펜-4-일-피페라진-1-일)부톡시]-1H-퀴놀린-2-온 또는 그 염을 함유하는 정제 | |
| JP7444775B2 (ja) | 活性薬を高装薬した経口薄フィルム剤 | |
| JP6875407B2 (ja) | Jakキナーゼ阻害剤またはその薬剤的に許容される塩を含有する医薬組成物 | |
| JP2014237658A5 (https=) | ||
| JPWO2014038593A1 (ja) | 口腔内速崩壊性錠剤用造粒物 | |
| MX2012013090A (es) | Formulaciones farmaceuticas que comprenden derivados de 1-(beta-d-glucopiranosil)-2-tienil-metilbenceno como inhibidores de transportadores de glucosa dependientes de sodio. | |
| KR20160000762A (ko) | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 및 그 제조방법 | |
| JP7104039B2 (ja) | 医薬組成物 | |
| JP2022515067A5 (https=) | ||
| EP2384745A2 (en) | Modified Release Pharmaceutical Compositions Of Dexlansoprazole | |
| RU2008147216A (ru) | Жидкая лекарственная композиция | |
| WO2019004447A1 (ja) | 医薬組成物 | |
| JP2025123520A (ja) | ニロチニブ錠剤 | |
| EP2723322B1 (en) | Imatinib mesylate oral pharmaceutical composition and process for preparation thereof | |
| JP2022515068A5 (https=) | ||
| JP6453858B2 (ja) | 共結晶形態でアゴメラチンを含むアゴメラチン製剤 | |
| JP2011012018A (ja) | 崩壊遅延が抑制されたパロキセチン塩酸塩水和物の経口投与用医薬組成物 | |
| JP2017002022A (ja) | ボリコナゾール含有製剤 | |
| EA010911B1 (ru) | Ингибиторы проникновения вируса вич | |
| CN101422441B (zh) | 尼美舒利缓释片及其制备方法 | |
| JP7355846B2 (ja) | 固形製剤 | |
| CZ300047B6 (cs) | Farmaceutická kompozice s obsahem úcinné látky atorvastatinu | |
| EP1713452A2 (en) | Sustained release pharmaceutical composition of indapamide | |
| BR112014026040B1 (pt) | Comprimido de liberação sustentada que contém levodropropizina | |
| RU2022105315A (ru) | Композиция мирабегрона и ее применение |